Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak.

Buonsenso D, Piano A, Raffaelli F, Bonadia N, de Gaetano Donati K, Franceschi F.

Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2776-2780. doi: 10.26355/eurrev_202003_20549.

2.

Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.

Rondy M, Castilla J, Launay O, Costanzo S, Ezpeleta C, Galtier F, de Gaetano Donati K, Moren A.

Hum Vaccin Immunother. 2016 May 3;12(5):1217-24. doi: 10.1080/21645515.2015.1126013. Epub 2016 Feb 2.

3.

2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.

Rondy M, Launay O, Puig-Barberà J, Gefenaite G, Castilla J, de Gaetano Donati K, Galtier F, Hak E, Guevara M, Costanzo S; European hospital IVE network, Moren A.

Euro Surveill. 2015 Jan 15;20(2). pii: 21011. Erratum in: Euro Surveill. 2015;20(3). pii: 21015. Niesters, Hubert [added].

4.

The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study.

De Luca A, de Gaetano Donati K, Colafigli M, Cozzi-Lepri A, De Curtis A, Gori A, Sighinolfi L, Giacometti A, Capobianchi MR, D'Avino A, Iacoviello L, Cauda R, D'Arminio Monforte A.

BMC Infect Dis. 2013 Sep 3;13:414. doi: 10.1186/1471-2334-13-414.

5.

2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study.

Rondy M, Puig-Barbera J, Launay O, Duval X, Castilla J, Guevara M, Costanzo S, de Gaetano Donati K, Moren A.

PLoS One. 2013;8(4):e59681. doi: 10.1371/journal.pone.0059681. Epub 2013 Apr 2.

6.

Chemotherapy-Induced Neutropenia in HIV Positive Patients with Lymphoma: Comparison of Pegfilgrastim with Daily Filgrastim Administration.

Teofili L, Izzi I, Nuzzolo ER, Scoppettuolo G, Torti L, Rossi M, de Gaetano Donati K.

Mediterr J Hematol Infect Dis. 2012;4(1):e2012062. doi: 10.4084/MJHID.2012.062. Epub 2012 Oct 3.

7.

Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: a longitudinal study.

De Luca A, de Gaetano Donati K, Cozzi-Lepri A, Colafigli M, De Curtis A, Capobianchi MR, Antinori A, Giacometti A, Magnani G, Vullo V, Cauda R, Iacoviello L, d'Arminio Monforte A; ICoNA Foundation Study Group.

J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):e98-101. doi: 10.1097/QAI.0b013e318259875b. No abstract available.

PMID:
22728753
8.

Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma.

Cingolani A, Torti L, Pinnetti C, de Gaetano Donati K, Murri R, Tacconelli E, Larocca LM, Teofili L.

AIDS. 2010 Sep 24;24(15):2408-12. doi: 10.1097/QAD.0b013e32833db989.

PMID:
20671541
9.

Fulminant endogenous gas gangrene: role of ultrasonography in the emergency setting.

Testa A, Giannuzzi R, de Gaetano Donati K, Gentiloni Silveri N.

Am J Emerg Med. 2010 Jun;28(5):643.e1-3. doi: 10.1016/j.ajem.2009.09.008. Epub 2010 Mar 26. No abstract available.

PMID:
20579573
10.

HIV Infection, Antiretroviral Therapy and Cardiovascular Risk.

de Gaetano Donati K, Cauda R, Iacoviello L.

Mediterr J Hematol Infect Dis. 2010;2(3):e2010034. doi: 10.4084/MJHID.2010.034. Epub 2010 Nov 11.

11.

Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.

Tumbarello M, Sanguinetti M, Trecarichi EM, La Sorda M, Rossi M, de Carolis E, de Gaetano Donati K, Fadda G, Cauda R, Posteraro B.

J Antimicrob Chemother. 2008 Dec;62(6):1379-85. doi: 10.1093/jac/dkn381. Epub 2008 Sep 8.

PMID:
18782778
12.

Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia.

Tumbarello M, Posteraro B, Trecarichi EM, Fiori B, Rossi M, Porta R, de Gaetano Donati K, La Sorda M, Spanu T, Fadda G, Cauda R, Sanguinetti M.

J Clin Microbiol. 2007 Jun;45(6):1843-50. Epub 2007 Apr 25.

13.

Partial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1 exposed uninfected individuals.

Trecarichi EM, Tumbarello M, de Gaetano Donati K, Tamburrini E, Cauda R, Brahe C, Tiziano FD.

AIDS Res Ther. 2006 Sep 25;3:22.

14.

Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy.

Tumbarello M, Rabagliati R, de Gaetano Donati K, Bertagnolio S, Montuori E, Tamburrini E, Tacconelli E, Cauda R.

BMC Infect Dis. 2004 Nov 6;4:46.

15.

Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome.

Bertagnolio S, de Gaetano Donati K, Tacconelli E, Scoppettuolo G, Posteraro B, Fadda G, Cauda R, Tumbarello M.

J Chemother. 2004 Apr;16(2):172-8.

PMID:
15216953
16.

HIV infection, HAART, and endothelial adhesion molecules: current perspectives.

de Gaetano Donati K, Rabagliati R, Iacoviello L, Cauda R.

Lancet Infect Dis. 2004 Apr;4(4):213-22. Review.

PMID:
15050939
17.

[Bacterial pneumonia in HIV-infected patients]

De Gaetano Donati K, Tacconelli E, Tumbarello M, Bertagnolo S, Ardito F, Pirronti T, Cauda R.

Infez Med. 1999;7(2):108-112. Italian.

18.

[Central venous catheter-related sepsis: one year experience in a large university hospital]

De Gaetano Donati K, Tacconelli E, Tumbarello M, Bertagnolio S, Pittiruti M, Leone F, Cauda R.

Infez Med. 1999;7(4):227-230. Italian.

19.

Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV-infected subjects.

de Gaetano Donati K, Tumbarello M, Tacconelli E, Bertagnolio S, Rabagliati R, Scoppettuolo G, Citton R, Cataldo M, Rastrelli E, Fadda G, Cauda R.

J Chemother. 2003 Feb;15(1):60-5.

PMID:
12678416
20.

Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy.

de Gaetano Donati K, Rabagliati R, Tumbarello M, Tacconelli E, Amore C, Cauda R, Lacoviello L.

AIDS. 2003 Mar 28;17(5):765-8. No abstract available.

PMID:
12646805
21.

Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario.

Tumbarello M, Rabagliati R, De Gaetano Donati K, Bertagnolio S, Tamburrini E, Tacconelli E, Cauda R.

AIDS. 2003 Jan 3;17(1):128-31. No abstract available.

PMID:
12478081
22.

Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients.

Tumbarello M, de Gaetano Donati K, Tacconelli E, Citton R, Spanu T, Leone F, Fadda G, Cauda R.

J Antimicrob Chemother. 2002 Sep;50(3):375-82.

PMID:
12205062
23.

Recurrent venous thrombosis in a patient with haemophilia A and HIV infection.

de Gaetano Donati K, Tacconelli E, Scoppettuolo G, De Stefano V, Cauda R, Tumbarello M.

Haematologica. 2002 Jan;87(1):ECR04. No abstract available.

PMID:
11801478
24.

Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome.

Tumbarello M, Tacconelli E, de Gaetano Donati K, Bertagnolio S, Cataldo M, Pirronti T, Ardito F, Cauda R.

Eur Respir J. 2001 Apr;17(4):636-40.

25.

Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects.

de Gaetano Donati K, Bertagnolio S, Tumbarello M, Tacconelli E, Cataldo M, Longo B, Cauda R.

Int J Antimicrob Agents. 2000 Nov;16(3):357-60.

PMID:
11091063
26.

Clostridium difficile-associated diarrhea in human immunodeficiency virus infection--a changing scenario.

Tacconelli E, Tumbarello M, de Gaetano Donati K, Leone F, Mazzella P, Cauda R.

Clin Infect Dis. 1999 Apr;28(4):936-7. No abstract available.

PMID:
10825082
27.

Morbidity associated with central venous catheter-use in a cohort of 212 hospitalized subjects with HIV infection.

Tacconelli E, Tumbarello M, de Gaetano Donati K, Bertagnolio S, Pittiruti M, Leone F, Morace G, Cauda R.

J Hosp Infect. 2000 Mar;44(3):186-92.

PMID:
10706801
28.

Candidemia in HIV-infected subjects.

Tumbarello M, Tacconelli E, de Gaetano Donati K, Morace G, Fadda G, Cauda R.

Eur J Clin Microbiol Infect Dis. 1999 Jul;18(7):478-83.

PMID:
10482024
29.

HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy.

Tumbarello M, Tacconelli E, de Gaetano Donati K, Cauda R.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Feb 1;20(2):208-9. No abstract available.

PMID:
10048911

Supplemental Content

Loading ...
Support Center